MX2019012050A - Composicion para usar en el tratamiento de la epilepsia. - Google Patents

Composicion para usar en el tratamiento de la epilepsia.

Info

Publication number
MX2019012050A
MX2019012050A MX2019012050A MX2019012050A MX2019012050A MX 2019012050 A MX2019012050 A MX 2019012050A MX 2019012050 A MX2019012050 A MX 2019012050A MX 2019012050 A MX2019012050 A MX 2019012050A MX 2019012050 A MX2019012050 A MX 2019012050A
Authority
MX
Mexico
Prior art keywords
composition
epilepsy
treatment
epileptic seizures
treating epilepsy
Prior art date
Application number
MX2019012050A
Other languages
English (en)
Inventor
Matthew Walker
Simon Eaton
Simon Heales
Aziza Khabbush
Maura Louise Odonnell
Patricia Rutherford
Robin- Simon- Brooke Williams
Original Assignee
Vitaflo Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vitaflo Int Ltd filed Critical Vitaflo Int Ltd
Publication of MX2019012050A publication Critical patent/MX2019012050A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Dairy Products (AREA)

Abstract

Una composición que comprende una relación de ácido decanoico a ácido octanoico de 70:30 A 90:10 p/p para usar en el tratamiento de la epilepsia o en el control de las convulsiones epilépticas.
MX2019012050A 2017-04-10 2018-04-09 Composicion para usar en el tratamiento de la epilepsia. MX2019012050A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17165690 2017-04-10
PCT/EP2018/059031 WO2018189113A1 (en) 2017-04-10 2018-04-09 Composition for use in the treatment of epilepsy

Publications (1)

Publication Number Publication Date
MX2019012050A true MX2019012050A (es) 2020-08-17

Family

ID=58544776

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019012050A MX2019012050A (es) 2017-04-10 2018-04-09 Composicion para usar en el tratamiento de la epilepsia.

Country Status (9)

Country Link
US (1) US11351138B2 (es)
EP (1) EP3609489A1 (es)
JP (2) JP7193471B2 (es)
CN (1) CN110678173B (es)
AU (2) AU2018250864B2 (es)
BR (1) BR112019020785A2 (es)
CA (1) CA3058047A1 (es)
MX (1) MX2019012050A (es)
WO (1) WO2018189113A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3609489A1 (en) * 2017-04-10 2020-02-19 Vitaflo International Ltd. Composition for use in the treatment of epilepsy
WO2021240540A1 (en) 2020-05-26 2021-12-02 Celagenex Research (India) Pvt. Ltd. Novel synergistic nutritional compositions for treating seizures and chronic inflammatory diseases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS591415A (ja) * 1982-06-28 1984-01-06 Mochida Pharmaceut Co Ltd 循環系疾患治療剤
EP0632008B1 (en) * 1993-06-01 1998-02-04 Ono Pharmaceutical Co., Ltd. Pentanoic acid derivatives
US6639089B2 (en) 2000-11-08 2003-10-28 Soda Aromatic Co., Ltd. Anticancer agents, perfumes or foods and drinks
EP2204172A4 (en) 2007-09-19 2010-09-22 Inst Nagoya Ind Science Res MEDIUM WITH NEUROTROPHIC FACTOR-SUBSTANTIVE EFFECT
JP5059947B2 (ja) * 2008-11-06 2012-10-31 日清オイリオグループ株式会社 濃厚流動食
GB201020133D0 (en) * 2010-11-26 2011-01-12 Royal Holloway & Bedford New College Therapeutic use of compounds
GB201210699D0 (en) * 2012-06-15 2012-08-01 Vitaflo Ltd Nutritional food
EP3609489A1 (en) 2017-04-10 2020-02-19 Vitaflo International Ltd. Composition for use in the treatment of epilepsy

Also Published As

Publication number Publication date
AU2018250864B2 (en) 2024-01-11
US20200147025A1 (en) 2020-05-14
RU2019135829A (ru) 2021-05-11
AU2018250864A1 (en) 2019-10-10
AU2024202292A1 (en) 2024-06-06
EP3609489A1 (en) 2020-02-19
JP2020518557A (ja) 2020-06-25
JP2023018063A (ja) 2023-02-07
CA3058047A1 (en) 2018-10-18
CN110678173B (zh) 2023-03-28
CN110678173A (zh) 2020-01-10
WO2018189113A1 (en) 2018-10-18
US11351138B2 (en) 2022-06-07
JP7193471B2 (ja) 2022-12-20
RU2019135829A3 (es) 2021-05-26
BR112019020785A2 (pt) 2020-04-28
JP7491491B2 (ja) 2024-05-28

Similar Documents

Publication Publication Date Title
MX2021008281A (es) Estimuladores de guanilato ciclasa soluble (sgc).
PH12017502298A1 (en) Antibacterial compounds
MX2020001732A (es) Tratamiento de las afecciones del sistema nervioso central.
MX2018012655A (es) Compuestos y metodos para tratamiento de afecciones neurologicas y cardiovasculares.
MY192055A (en) Compounds and compositions for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formation
NZ737435A (en) Prodrugs of fumarates and their use in treating various diseases
PH12016501654A1 (en) Diacylglycerol acyltransferase 2 inhibitors for use in the treatment of metabolic and related disorders
JOP20200035A1 (ar) تركيبات حمض أميني لعلاج الإصابات العصبية
NZ710444A (en) Compositions and methods for treating neurodegenerative diseases and cardiomyopathy
MX2022009155A (es) Nuevos profarmacos polimericos de la hormona del crecimiento humana (hgh).
PH12016500140A1 (en) Heterobicycloaryl rorc2 inhibitors and methods of use thereof
MX2019013808A (es) Compuestos desestabilizadores de microtubulina para usarse en el tratamiento del cancer.
PH12019500177A1 (en) Treatment and prevention of sleep disorders
NZ738672A (en) Therapeutic compounds and compositions for treating social disorders and substance use disorders
MX2016015896A (es) Composiciones que contienen azufre polimerico y usos de estas.
MX2019012050A (es) Composicion para usar en el tratamiento de la epilepsia.
WO2016134257A8 (en) Oxabicycloheptanes and oxabicycloheptenes for the treatment of depressive and stress disorders
BR112017007916A2 (pt) compostos sarms para tratamento de distúrbios urológicos
MX2018009662A (es) Metodo y composicion farmaceutica para tratamiento de neurodegeneracion.
MX2017005058A (es) Composicion para el tratamiento de ectoparasitosis y la promocion del crecimiento en acuicultura.
MX2019014313A (es) Combinacion que comprende acido decanoico para el tratamiento de la epilepsia.
IL288307A (en) Preparations for use in the treatment of insulin deficiency conditions
PH12019502028A1 (en) Deodorizing/antibacterial agent
MX2016016118A (es) Métodos de tratamiento de enfermedades y trastornos del neurodesarrollo.
WO2019040104A3 (en) COMPOUNDS, RELATED SALTS AND METHODS OF TREATING DISEASES